| Date | Research Title | Institution |
|---|
| March 2007 |
|---|
| Harry W. Schroeder, Jr., MD, Ph.D. | HLA*B44 and memory B cells in patients with sino-pulmonary infections | University of Alabama at Birmingham |
| November 2006 |
|---|
| Jennifer M. Puck, MD | T Cell Receptor Excision Circles (TRECs): a Newborn Screening Tool for SCID | University of California, San Francisco |
| Marie Jose Stasia, Ph.D. | X+CGD and Nox2 superoxidase mutants powerful tools to study NADPH oxidase activation | Universite Joseph Fourier |
| Troy R. Torgerson, MD | A Cell Instrinic Role for FOXP3 in the Human Immune System | Children's Hospital & Regional Medical Center |
| July 2006 |
|---|
| Eyal Grunebaum, MD | Correcting PNP Deficiencies by intracellular delivery of PNP fused to PTD | Hospital for Sick Children |
| Peter E. Newburger, MD | Novel approach to oral gene therapy for CGD | University of Massachusetts Medical School |
| March 2006 |
|---|
| Peter K. Gregersen, MD | Whole genome association studies in CVID and IGAD | North Shore LIJ Health System |
| Lisa Borghesi, Ph.D. | Regulation of E47 activity and V(D)J recombination in mouse and man | University of Pittsburgh |
| Brian R. Davis, Ph.D. | Nuclease facilitated gene editing for PIDD | Institute for Inherited Disease Research |
| Michael B. Jordan, MD | Immune regulation in hemophagocytic lymphohistiocytosis | Cincinnati Children's Hospital |
| November 2005 |
|---|
| Anna M. Blom, MSc, Ph.D. | Deficiencies of complement inhibitors | Lund University |
| Scott B. Snapper, MD, Ph.D. | Targeting C-linked neutropenia:Strategies to investigate an activated WASP | Massachusetts General Hospital |
| July 2005 |
|---|
| David T. Teachey, MD | Improving treatment of the autoimmune lymphoproliferative syndrome | Children's Hospital of Philadelphia |
| March 2005 |
|---|
| Bodo Grimbacher, MD | Genetics of antibody deficiency syndrome | University College London |
| Emanuela Castigli, Ph.D. | IgAD and CVID:role of APRIL/BAFF-TACI and BAFF-R axes | Children's Hospital Boston |
| Douglas McDonald, MD, Ph.D. | Novel immunodeficiency involving toll-like receptor7,8,9 defects | Children's Hospital Boston |
| Janos Sumegi, MD, Ph.D. | The binding repertoire of the Duncan Disease (XLP) gene product SAP | Cincinnati Children's Hospital |
| November 2004 |
|---|
| Carol Miao, Ph.D. | Gene therapy for Wiskott-Aldrich Syndrome | Children's Hospital and Regional Medical Center |
| Yatin Vyas, MD | Role of Human WASp in lymphocyte signaling | Children's Hospital of Pittsburgh |
| July 2004 |
|---|
| Anthony Infante, MD, Ph.D. | Thymus in mouse model of DiGeorge Syndrome | Univ. of Texas Health Science |
| Jordan Orange, MD, Ph.D. | Human NEMO mutation and immunodeficiency | Children's Hospital of Philadelphia |
| Carol Webb, Ph.D. | Role for human bright in XLA | Oklahoma Medical Research Foundation |
| March 2004 |
|---|
| Ramsay Fuleihan, MD | Toward gene therapy of X-linked hyper IgM | Yale University School of Medicine |
| Donald Kohn, MD | A site specific gene therapy method to ameliorate PIDD | Children's Hospital Los Angeles |
| Narayanaswamy Ramesh, Ph.D. | Role of WIP in WASP homeostasis | Children's Hospital Boston |
| January 2004 |
|---|
| Andrew Scharenberg, MD | Signaling competent transformed cell lines for functional analysis | University of Washington |
| Charlotte Cunningham-Rundles, MD, Ph.D. | Investigation of ICOS and other signaling pathways in CVID | Mt. Sinai School of Medicine |
| Kim Nichols, MD | SRC Homology 2 (SH2) domain containing gene 1A (SH2D1A) | Children's Hospital of Philadelphia |
